Beyond statistical association: Interpreting the clinical utility of biomarkers for incident heart failure prediction Authors: Yaqun Tang, Haijun Chen Published: 2026 Dear Editor, The systematic review by Noordermeer et al. [1] offers a thorough synthesis of evidence linking cardiac, oxidative stress, and fibrosis-related biomarkers to new-onset heart failure (HF). We agree that these findings strengthen the case for biomarker-informed HF risk assessment. That said, we believe the field now needs to move beyond establishing associations and toward demonstrating whether these markers genuinely improve clinical decision-making. The distinction matters. Neumann et al. [2] tested 28 cardiovascular biomarkers across more than 160,000 individuals and reported that NT-proBNP, the strongest predictor of HF risk, improved the C-statistic from 0.812 to 0.819 (Δ = 0.007) when added to conventional risk factors. As Mangalesh and Nanna pointed out in their editorial [3], such modest increments raise questions about real-world predictive value. Indeed, the GUIDE-IT trial [4] showed that NT-proBNP-guided therapy did not reduce HF hospitalization or cardiovascular mortality compared with usual care in patients with HFrEF, illustrating that strong associations do not automatically translate into effective management strategies. There is also the issue of HF heterogeneity. Biomarkers such as GDF-15 and Gal-3 reflect not only systemic inflammation and fibrosis but potentially HF-specific processes like myocardial stress. Stratifying their predictive performance by HF phenotype, HFrEF versus HFpEF, and evaluating incremental utility for clinical risk stratification [5] would help determine which markers, if any, deserve a place in routine practice. Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. CRediT authorship contribution statement Yaqun Tang: Writing – original draft. Haijun Chen: Conceptualization, Software, Supervision, Writing – review & editing. Declaration of competing interests The authors have no conflicts of interest to report. References